Biotech / Medical : Isis Pharmaceuticals (ISIP)


 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: DewDiligence_on_SI who wrote (4647)5/6/2011 7:27:06 PM
From: bob zagorin of 4667
 
thanks.. mipo filing info from cc..

from the transcript "...Most significant events of this year should be the mipomersen filings for marketing approval in Europe and U.S. Not only it is an important event for Genzyme and us, plus important for sanofi. In fact sanofi highlighted mipomersen regulatory filings as important upcoming milestones in both their earnings press release and their conference call last week.

We are obviously very pleased with the progress the teams have made and now can confidently tell you that European filing will be in July. In the US, our initial filing is also on track to be filled in the second half of this year. Some of the most exciting progress that has been made recently is the evolution of Genzyme’s plans for commercialization of mipomersen...."
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

Copyright © 1995-2013 Knight Sac Media. All rights reserved.